• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者睾丸切除术后血清中前列腺特异性抗原和前列腺酸性磷酸酶的预后价值。

The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.

作者信息

Dutkiewicz S, Stawarz B, Lypka A, Zieliński H

机构信息

Department of Clinical Urology, C.C.H. M.M.A., Warsaw, Poland.

出版信息

Int Urol Nephrol. 1992;24(4):409-16. doi: 10.1007/BF02550635.

DOI:10.1007/BF02550635
PMID:1281145
Abstract

Correlations between the serum levels of PAP and PSA before and 1, 3 and 6 months after orchidectomy in 27 prostatic cancer patients (advanced clinical stages C and D according to Whitemore scale) were studied. The PSA values correlated more distinctly than PAP with the general clinical condition. PSA is a reliable tumour marker when used at regular intervals, especially for monitoring therapeutic results. A high preoperative PSA level correlates with a high postoperative level and progression of the disease.

摘要

对27例前列腺癌患者(根据怀特莫尔分期为临床晚期C期和D期)在睾丸切除术前以及术后1个月、3个月和6个月时血清PAP和PSA水平之间的相关性进行了研究。PSA值与总体临床状况的相关性比PAP更明显。定期使用时,PSA是一种可靠的肿瘤标志物,尤其适用于监测治疗效果。术前PSA水平高与术后水平高及疾病进展相关。

相似文献

1
The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.前列腺癌患者睾丸切除术后血清中前列腺特异性抗原和前列腺酸性磷酸酶的预后价值。
Int Urol Nephrol. 1992;24(4):409-16. doi: 10.1007/BF02550635.
2
Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer.D2期前列腺癌内分泌治疗后前列腺特异性标志物变化的预后意义
Cancer. 1992 Nov 1;70(9):2302-9. doi: 10.1002/1097-0142(19921101)70:9<2302::aid-cncr2820700915>3.0.co;2-2.
3
Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.前列腺特异性抗原与前列腺酸性磷酸酶在前列腺癌治疗中的比较。
Am J Clin Oncol. 1988;11 Suppl 2:S77-9. doi: 10.1097/00000421-198801102-00019.
4
Prognostic value of prostate-specific antigen minimum after orchidectomy in patients with stage C and D prostatic carcinoma.
Br J Urol. 1995 Jul;76(1):34-40. doi: 10.1111/j.1464-410x.1995.tb07828.x.
5
Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.前列腺癌患者前列腺特异性抗原、临床分期与骨转移程度之间的关系:与前列腺酸性磷酸酶和碱性磷酸酶的比较
Int J Urol. 1997 Nov;4(6):572-5. doi: 10.1111/j.1442-2042.1997.tb00311.x.
6
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?良性前列腺增生中前列腺酸性磷酸酶与前列腺特异性抗原血清水平及前列腺体积的关系。原发性前列腺癌肿瘤标志物评估中的陷阱?
Eur Urol. 1992;21 Suppl 1:108-10. doi: 10.1159/000474905.
7
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Eur Urol. 1992;22(1):33-8. doi: 10.1159/000474718.
8
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.内分泌治疗难治性前列腺癌患者的预后因素:单因素和多因素分析,包括前列腺特异性抗原和前列腺酸性磷酸酶的倍增时间
Jpn J Clin Oncol. 1997 Aug;27(4):258-62. doi: 10.1093/jjco/27.4.258.
9
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Eur Urol. 1992;21(4):263-8. doi: 10.1159/000474854.
10
[Role of the markers PAP-PSA in the diagnosis of cancer of the prostate].
Minerva Urol Nefrol. 1990 Apr-Jun;42(2):73-5.

引用本文的文献

1
Effect of digital rectal examination on plasma prostate-specific antigen (PSA).直肠指检对血浆前列腺特异性抗原(PSA)的影响。
Int Urol Nephrol. 1996;28(2):211-4. doi: 10.1007/BF02550863.
2
Relationship between prostate-specific antigen, prostate volume, retention volume and age in benign prostatic hypertrophy (BPH).良性前列腺增生(BPH)中前列腺特异性抗原、前列腺体积、残余尿量与年龄之间的关系。
Int Urol Nephrol. 1995;27(6):763-8. doi: 10.1007/BF02552144.
3
The deiodination of thyroxine to triiodothyronine in the testes of patients with prostate cancer.

本文引用的文献

1
New methods of endocrine management of prostatic cancer.
J Urol. 1987 Jan;137(1):1-10. doi: 10.1016/s0022-5347(17)43855-9.
2
Prostatic acid phosphatase: its current clinical status.前列腺酸性磷酸酶:其当前的临床状况。
J Urol. 1987 Jun;137(6):1091-103. doi: 10.1016/s0022-5347(17)44414-4.
3
Cancer statistics, 1989.1989年癌症统计数据。
CA Cancer J Clin. 1989 Jan-Feb;39(1):3-20. doi: 10.3322/canjclin.39.1.3.
Int Urol Nephrol. 1995;27(1):81-5. doi: 10.1007/BF02575224.
4
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.前列腺特异性抗原作为前列腺腺癌的血清标志物。
N Engl J Med. 1987 Oct 8;317(15):909-16. doi: 10.1056/NEJM198710083171501.
5
Androgen receptors in cancer of the prostate. Correlation with the stage and grade of the tumor.
Cancer. 1986 Jun 15;57(12):2351-6. doi: 10.1002/1097-0142(19860615)57:12<2351::aid-cncr2820571219>3.0.co;2-f.
6
[The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].[前列腺特异性抗原在前列腺腺癌诊断与治疗中的作用]
Urologe A. 1990 Mar;29(2):52-64.